Is Teladoc Stock a Buy?
Investor sentiment surrounding Teladoc (NYSE: TDOC) has been bad for a while now. The telemedicine specialist's stock is down 95% from its all-time high in 2021.
Teladoc's business boomed during the early days of the COVID-19 pandemic, benefiting enormously by providing at-home virtual care to patients. But like so many of the other "stay-at-home" stocks, Teladoc has struggled mightily since life returned to normal. The company is not currently profitable, and with demand for virtual care waning, investors have mostly thrown in the towel.
To cap off the misery of the past three years, Teladoc's CEO abruptly left the at the beginning of April, catching investors off-guard, with the company giving no reason for the change in leadership. The company named CFO Mala Murthy as acting chief executive officer while it searches for a replacement leader. Murthy remains CFO as well.
Source Fool.com
